Scarica l'app Stockscreener
0.6005
1.88%
-0.0115
Precedente Chiudi:
$0.612
Aprire:
$0.652
Volume 24 ore:
48,086
Relative Volume:
0.49
Capitalizzazione di mercato:
$10.23M
Reddito:
$2.82M
Utile/perdita netta:
$-14.20M
Rapporto P/E:
-0.7065
EPS:
-0.85
Flusso di cassa netto:
$-15.13M
1 W Prestazione:
-10.37%
1M Prestazione:
-4.71%
6M Prestazione:
-34.08%
1 anno Prestazione:
-50.78%
Intervallo 1D:
$0.6002
$0.67
Intervallo di 1 settimana:
$0.6002
$0.67
Portata 52W:
$0.501
$1.50
Talphera Inc Stock (TLPH) Company Profile
Nome
Talphera Inc
Settore
Telefono
650-216-3500
Indirizzo
1850 GATEWAY DRIVE, SAN MATEO
Confronta TLPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLPH
Talphera Inc
|
0.6005 | 10.23M | 2.82M | -14.20M | -15.13M | -0.85 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-28 | Iniziato | Rodman & Renshaw | Buy |
| 2020-07-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2019-11-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-08-05 | Ripresa | Credit Suisse | Outperform |
| 2019-07-10 | Ripresa | Credit Suisse | Outperform |
| 2019-04-24 | Ripresa | B. Riley FBR | Buy |
| 2019-02-15 | Iniziato | Credit Suisse | Outperform |
| 2018-10-23 | Iniziato | B. Riley FBR | Buy |
| 2017-10-13 | Downgrade | Jefferies | Buy → Hold |
| 2017-10-13 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-07-14 | Ripresa | Jefferies | Buy |
| 2016-09-15 | Reiterato | ROTH Capital | Buy |
| 2016-08-05 | Downgrade | Stifel | Buy → Hold |
| 2015-10-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2015-10-05 | Reiterato | ROTH Capital | Buy |
| 2015-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2015-07-10 | Ripresa | ROTH Capital | Buy |
| 2015-05-06 | Reiterato | Mizuho | Neutral |
| 2015-05-05 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-03-10 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-03-09 | Downgrade | Mizuho | Buy → Neutral |
Mostra tutto
Talphera Inc Borsa (TLPH) Ultime notizie
Talphera Inc (NASDAQ: TLPH) Is On The Rise - Stocks Register
RODMAN&RENSHAW Upgrades Talphera (NASDAQ:TLPH) to Strong-Buy - Defense World
Rodman & Renshaw sets Talphera stock Buy rating, $4 target - MSN
Talphera (NASDAQ:TLPH) Receives “Buy” Rating from HC Wainwright - Defense World
FDA to review Talphera's request to amend NEPHRO study By Investing.com - Investing.com Canada
FDA to review Talphera’s request to amend NEPHRO study By Investing.com - Investing.com Nigeria
FDA to review Talphera's request to amend NEPHRO study - Investing.com
Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - The Eastern Progress Online
TLPH stock touches 52-week low at $0.6 amid market shifts - Investing.com UK
TLPH stock touches 52-week low at $0.61 amid market challenges - Investing.com
Talphera faces Nasdaq delisting over share price rule - Investing.com
Talphera faces Nasdaq delisting over share price rule By Investing.com - Investing.com UK
Acelrx Announces Dsuvia® Milestone C Approval; Provides Revenue Guidance for the First Quarter 2020 - Marketscreener.com
Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 - Kilgore News Herald
Talphera CEO Vincent J. Angotti acquires $3,199 in common stock - Investing.com
Talphera CEO Vincent J. Angotti acquires $3,199 in common stock By Investing.com - Investing.com UK
Talphera CEO Vincent J. Angotti buys $3,649 in company stock By Investing.com - Investing.com Canada
Talphera CFO Raffi Asadorian sells shares worth $118 - Investing.com India
Talphera CEO Vincent J. Angotti buys $3,649 in company stock - Investing.com India
Talphera CFO Raffi Asadorian sells shares worth $118 By Investing.com - Investing.com Canada
Talphera Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.085 loss in 3Q 2023) - Yahoo Finance
Talphera (FRA:R5XA) Inventories, Raw Materials & Components : €0.00 Mil (As of Jun. 2024) - GuruFocus.com
Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges - GuruFocus.com
Talphera: Q3 Earnings Snapshot - mySA
Talphera Reports Q3 2024 Results and Study Progress - TipRanks
Talphera's Q3 Loss Widens to $3.4M as NEPHRO Trial Expands to New Sites | TLPH Stock News - StockTitan
Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PR Newswire
An Overview of Talphera's Earnings - Benzinga
Talphera Sets Q3 2024 Earnings Call for November 13Key Financial Results Update | TLPH Stock News - StockTitan
Talphera, Inc. (NASDAQ:TLPH) Sees Large Decline in Short Interest - Defense World
Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - Citizentribune
Talphera extends agreement deadline with Nantahala Management By Investing.com - Investing.com Australia
Talphera extends agreement deadline with Nantahala Management - Investing.com
Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Kilgore News Herald
Talphera CEO Vincent J. Angotti buys $7.6k in company stock - Investing.com
Credit Suisse gives an Underperform recommendation for Talphera Inc. (TLPH) - Knox Daily
TLPH Stock Earnings: Talphera Beats EPS for Q2 2024 - MSN
Talphera starts key trial for anticoagulant nafamostat - Investing.com
Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit - PR Newswire
Talphera First Half 2024 Earnings: US$0.31 loss per share (vs US$0.40 loss in 1H 2023) - Yahoo Finance
Talphera Inc (TLPH) Q2 2024 Earnings Call Transcript Highlights: Strategic Advancements and Financial Adjustments - GuruFocus.com
Talphera: Q2 Earnings Snapshot - San Antonio Express-News
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update - Longview News-Journal
Talphera Inc Azioni (TLPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Talphera Inc Azioni (TLPH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ASADORIAN RAFFI | Chief Financial Officer |
Dec 02 '24 |
Sale |
0.77 |
155 |
119 |
37,578 |
| Angotti Vincent J. | CHIEF EXECUTIVE OFFICER |
Nov 27 '24 |
Buy |
0.73 |
5,000 |
3,650 |
203,066 |
3.23%
3.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):